NCT03340961View on ClinicalTrials.gov

A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules

PHASE2CompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

November 7, 2018

Study Completion Date

March 31, 2019

Conditions
Rosacea
Interventions
DRUG

DFD-29 Extended Release Capsules (40 mg)

Oral Treatment

DRUG

DFD-29 Extended Release Capsules (20 mg)

Oral Treatment

DRUG

Oraycea® (doxycycline) Capsules

Oral Treatment

DRUG

Placebo Capsules

Oral Treatment

Trial Locations (14)

Unknown

Site 13, Bad Bentheim

Site 07, Berlin

Site 14, Berlin

Site 09, Bochum

Site 05, Buxtehude

Site 15, Darmstadt

Site 03, Dülmen

Site 08, Leipzig

Site 11, Mahlow

Site 06, Münster

Site 10, Osnabrück

Site 01, Pommelsbrunn

Site 04, Potsdam

Site 02, Wuppertal

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY